Page last updated: 2024-10-28

haloperidol and Frontotemporal Dementia

haloperidol has been researched along with Frontotemporal Dementia in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Frontotemporal Dementia: The most common clinical form of FRONTOTEMPORAL LOBAR DEGENERATION, this dementia presents with personality and behavioral changes often associated with disinhibition, apathy, and lack of insight.

Research Excerpts

ExcerptRelevanceReference
"A 60-year-old man with rapidly progressive frontotemporal dementia complicated by severe aggression was managed in specialised psychogeriatric services and high-dose haloperidol was used."3.80Managing severe aggression in frontotemporal dementia. ( Flynn, P; McKellar, D; Powell, A; Rischbieth, S, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Powell, A1
Flynn, P1
Rischbieth, S1
McKellar, D1

Other Studies

1 other study available for haloperidol and Frontotemporal Dementia

ArticleYear
Managing severe aggression in frontotemporal dementia.
    Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2014, Volume: 22, Issue:1

    Topics: Aggression; Antipsychotic Agents; Basal Ganglia Diseases; Cognition Disorders; Death; Fatal Outcome;

2014